# US 2008/0269205 A1 · Methods to prevent vertical transmission of infectious diseases

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2008/0269205 A1
- Document ID: US20080269205A1
- Status: Published application
- Kind: A1
- Application number: 11/877,212
- Filed: 2007-10-23
- Published: 2008-10-30
- Earliest claimed: 2007-04-27
- Assignees: Ondine International, Ltd.
- Inventors: Nicolas G. Loebel; Roger Andersen
- Web page: https://patentgrep.com/patent/US20080269205A1

## CPC

- A61N 5/0624: {for eliminating microbes, germs, bacteria on or in the body}
- A61N 5/0601: {Apparatus for use inside the body}
- A61N 5/062: {Photodynamic therapy, i.e. excitation of an agent}
- A61P 31/12: Antivirals
- A61N: ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY (measurement of bioelectric currents A61B; surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body A61B18/00; anaesthetic apparatus in general A61M; incandescent lamps H01K; infrared radiators for heating H05B)
- A61P: SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS

## Abstract

The present invention presents a method of preventing vertical transmission of an infectious disease comprising: (a) applying a photosensitizing composition to host tissues of birth canal of a mother during the intrapartum period; and (b) applying light to the host tissues after the step (a) at a wavelength absorbed by the photosensitizing composition so as to inhibit or eliminate infectious disease microorganisms that come into contact with the host tissues. The infectious disease may be caused by human immunodeficiency virus type 1, hepatitis B virus, hepatitis C virus, Group B Streptococcus, cytomegalovirus, Listeria monocytogenes, Chiamydia trachomatis, Escherichia coli, herpes simplex virus, Epstein-Barr virus, Toxoplasma gondii, human papilloma virus, and Candida.

## Claims

### Claim 1

A method of preventing vertical transmission of an infectious disease comprising:
(a) Applying a photosensitizing composition to host tissues of a birth canal of a mother during intrapartum period; and
(b) Applying light to the host tissues after the step (a) at a wavelength absorbed by the photosensitizing composition so as to inhibit or eliminate infectious disease causing microorganisms that come into contact with the host tissues.

### Claim 2 (depends on 1)

The method of claim 1, the infectious disease causing microorganisms are selected from a group consisting of: human immunodeficiency virus type 1, hepatitis B virus, hepatitis C virus, Group B Streptococcus, cytomegalovirus, Listeria monocytogenes, Chlamydia trachomatis, Escherichia coli, herpes simplex virus, Epstein-Barr virus, Toxoplasma gondii, human papilloma virus and Candida.

### Claim 3 (depends on 1)

The method of claim 1, wherein the step (b) takes place after the photosensitizing composition has been placed into contact with the host tissues of the birth canal for at least 30 seconds.

### Claim 4 (depends on 1)

The method of claim 1, wherein duration of the step (b) is from about 3 minutes to about 10 minutes.

### Claim at position 5 (depends on 1)

5 The method of claim 1, wherein the light energy provided during the step (b) ranges from about 5 J/cm2 to about 20 J/cm2,

### Claim 6 (depends on 1)

The method of claim 1 wherein the steps (a) and (b) are repeated at least every hour during the intrapartum period.

### Claim 7 (depends on 1)

The method of claim 1 further comprising of performing the steps (a) and (b) at least about 5 minutes prior to the intrapartum period.

### Claim 8 (depends on 1)

The method of claim 1 further comprising:
(c) Applying sonic energy to the host tissues after the step (b).

### Claim 9 (depends on 8)

The method of claim 8 wherein the steps (a), (b) and (c) does not cause any physiological damage to the host tissues.

### Claim 10 (depends on 8)

The method of claim 8 wherein the steps (a), (b) and (c) are repeated at least every hour during the intrapartum period.

### Claim 11 (depends on 8)

The method of claim 8 wherein the step (c) is comprised of:
Applying ultrasound gel to the host tissues;
Applying sonic energy to the host tissues at a vibration ranging from about 2 MHz to about 5 MHz.

### Claim 12 (depends on 11)

The method of claim 11 wherein the applying ultrasound gel to the host tissues step is achieved by applying the ultrasound gel onto a vaginal ultrasound probe and inserting the vaginal ultrasound probe into the birth canal.

### Claim 13 (depends on 8)

The method of claim 8 wherein the light required for the step (b) and the sonic energy required for the step (c) are both provided by a vaginal probe.

### Claim 14 (depends on 13)

The method of claim 13 wherein the vaginal probe is comprised of a member having a base portion, an insert portion adapted for insertion into a vagina of a mother and for providing desired illumination pattern for the step (b), and a pocket adapted for communication with a waveguide wherein the pocket includes a light dispersing section that is adapted for light communication with distal end of the waveguide which is connected to a light source for delivering light to the insert portion, and the member further includes an electronic assembly adapted for providing the sonic energy.

### Claim 15 (depends on 8)

The method of claim 8, wherein the step (c) is comprised of:
Applying ultrasound gel to skin of abdominal area located above the host tissues; and
Applying sonic energy to the host tissues.

### Claim 16

A method of preventing vertical transmission of human immunodeficiency virus type 1 comprising:
(a) Applying a photosensitizing composition comprising of methylene blue to host tissues of a birth canal of a mother during intrapartum period;
(b) Applying light to the host tissues after the step (a) at a wavelength from about 650 nm to about 685 nm that is absorbed by the photosensitizing composition so as to inhibit or eliminate human immunodeficiency virus type 1 that comes into contact with the host tissues; and repeating the steps (a) and (b) at least every two hour during the intrapartum period.

### Claim 17 (depends on 16)

The method of claim 16 further comprising:
(c) Applying sonic energy to the birth canal after the step (b) using a sonic device.

### Claim 18 (depends on 16)

The method of claim 16 wherein the method does not cause any physiological damage to the host tissues.

### Claim 19 (depends on 16)

The method of claim 16, wherein the step (b) takes place after the photosensitizing composition has been placed into contact with the host tissues of the birth canal for at least 10 seconds.

### Claim 20 (depends on 16)

The method of claim 16, wherein duration of the step (b) is from about 1 minute to about 15 minutes.

### Claim 21

A method of preventing vertical transmission of hepatitis comprising:
(a) Applying a photosensitizing composition comprising of methylene blue to host tissues of a birth canal of a mother during intrapartum period;
(b) Applying light to the host tissues after the step (a) at a wavelength from about 660 nm to about 680 nm that is absorbed by the photosensitizing composition so as to inhibit or eliminate at least one type of hepatitis viruses that comes into contact with the host tissues; and repeating the steps (a) and (b) at least every two hour during the intrapartum period.

### Claim 22 (depends on 21)

The method of claim 21, wherein the methylene blue is at a concentration range from about 0.1 wt % to about 1 wt %.

### Claim 23 (depends on 21)

The method of claim 21, wherein the at least one type of hepatitis viruses is comprised of hepatitis C virus.

### Claim 24 (depends on 21)

The method of claim 21, wherein the at least one type of epatitis viruses is comprised of hepatitis B virus.
